Viatris Pre-Paid Expenses 2010-2024 | VTRS

Viatris pre-paid expenses from 2010 to 2024. Pre-paid expenses can be defined as a current asset created by prepayment of costs and expenses for which the benefits will occur at a future date.
  • Viatris pre-paid expenses for the quarter ending September 30, 2024 were $1.627B, a 8.84% decline year-over-year.
  • Viatris pre-paid expenses for 2023 were $2.028B, a 11.98% increase from 2022.
  • Viatris pre-paid expenses for 2022 were $1.811B, a 7.48% decline from 2021.
  • Viatris pre-paid expenses for 2021 were $1.958B, a 14.65% increase from 2020.
Viatris Annual Pre-Paid Expenses
(Millions of US $)
2023 $2,028
2022 $1,811
2021 $1,958
2020 $1,707
2019 $552
2018 $518
2017 $766
2016 $756
2015 $597
2014 $2,296
2013 $453
2012 $244
2011 $168
2010 $188
2009 $232
Viatris Quarterly Pre-Paid Expenses
(Millions of US $)
2024-09-30 $1,627
2024-06-30 $1,757
2024-03-31 $1,933
2023-12-31 $2,028
2023-09-30 $1,785
2023-06-30 $1,725
2023-03-31 $1,764
2022-12-31 $1,811
2022-09-30 $1,700
2022-06-30 $1,698
2022-03-31 $1,764
2021-12-31 $1,958
2021-09-30 $2,124
2021-06-30 $2,110
2021-03-31 $2,040
2020-12-31 $1,707
2020-09-30 $684
2020-06-30 $602
2020-03-31 $614
2019-12-31 $552
2019-09-30 $575
2019-06-30 $574
2019-03-31 $545
2018-12-31 $518
2018-09-30 $583
2018-06-30 $588
2018-03-31 $728
2017-12-31 $766
2017-09-30 $883
2017-06-30 $792
2017-03-31 $922
2016-12-31 $756
2016-09-30 $922
2016-06-30 $716
2016-03-31 $697
2015-12-31 $597
2015-09-30 $594
2015-06-30 $2,262
2015-03-31 $2,606
2014-12-31 $2,296
2014-09-30 $1,894
2014-06-30 $472
2014-03-31 $460
2013-12-31 $453
2013-09-30 $369
2013-06-30 $440
2013-03-31 $274
2012-12-31 $244
2012-09-30 $178
2012-06-30 $209
2012-03-31 $224
2011-12-31 $168
2011-09-30 $198
2011-06-30 $161
2011-03-31 $195
2010-12-31 $188
2010-09-30 $77
2010-06-30 $142
2010-03-31 $152
2009-12-31 $232
2009-09-30 $111
2009-06-30 $100
2009-03-31 $114
Sector Industry Market Cap Revenue
Medical Medical Services $15.815B $15.427B
Viatris, Inc. is a global healthcare company. Its portfolio comprises more than thousand approved molecules across a wide range of key therapeutic areas, including globally recognized iconic and key brands, generic, complex generic, and biosimilar products. Branded products include EpiPen, Amitiza, Lipitor and Viagra. Biosimilars portfolio include pegfilgrastim, trastuzumab and adalimumab biosimilars. It has obtained approval for the biosimilar of Avastin and Insulin Aspart in Europe. The company reports in following segments: Developed Markets, Greater China, JANZ & Emerging Markets. The Developed Markets segment comprises operations in N. America and Europe. The Greater China segment operates in China, Taiwan and Hong Kong. The JANZ segment will report for operations in Japan, Australia and New Zealand, while the Emerging Markets segment will include operations in Asia, the Middle East, South and Central America, Africa and E. Europe. This segment also includes the company's anti-retroviral franchise.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $93.604B 11.61
Cencora (COR) United States $48.412B 17.85
DiDi Global (DIDIY) China $22.941B 0.00
Natera (NTRA) United States $22.359B 0.00
ICON (ICLR) Ireland $17.552B 15.63
Avantor (AVTR) United States $13.857B 20.78
Revvity (RVTY) United States $13.522B 23.49
CochLear (CHEOY) Australia $12.586B 0.00
BioMerieux (BMXMF) France $12.119B 0.00
Solventum (SOLV) United States $12.029B 0.00
Medpace Holdings (MEDP) United States $10.624B 29.93
Charles River Laboratories (CRL) United States $9.930B 19.19
HealthEquity (HQY) United States $9.139B 49.60
Doximity (DOCS) United States $8.961B 52.75
Sonic Healthcare (SKHHY) Australia $8.813B 0.00
Bausch + Lomb (BLCO) Canada $6.977B 32.47
Life Times (LTH) United States $5.046B 33.40
Organon (OGN) United States $3.835B 3.87
Sotera Health (SHC) United States $3.515B 18.80
BrightSpring Health Services (BTSG) United States $3.265B 69.44
Surgery Partners (SGRY) United States $2.968B 33.84
Concentras Parent (CON) United States $2.735B 0.00
PACS (PACS) United States $2.522B 0.00
Alignment Healthcare (ALHC) United States $2.320B 0.00
Ardent Health Partners (ARDT) United States $2.255B 0.00
Premier (PINC) United States $2.155B 11.21
Ryman Healthcare (RYHTY) New Zealand $1.995B 0.00
GeneDx Holdings (WGS) United States $1.980B 0.00
Teladoc Health (TDOC) United States $1.791B 0.00
GoodRx Holdings (GDRX) United States $1.635B 42.90
Progyny (PGNY) United States $1.275B 25.81
Pediatrix Medical (MD) United States $1.267B 12.40
CareDx (CDNA) United States $1.211B 0.00
Establishment Labs Holdings (ESTA) $1.193B 0.00
AMN Healthcare Services Inc (AMN) United States $0.978B 6.62
Embecta (EMBC) United States $0.808B 5.38
QDM (QDMI) Hong Kong, SAR China $0.790B 20.69
Agilon Health (AGL) United States $0.733B 0.00
SBC Medicals (SBC) United States $0.670B 0.00
InnovAge Holding (INNV) United States $0.627B 0.00
Auna S.A (AUNA) Luxembourg $0.526B 0.00
Sonida Senior Living (SNDA) United States $0.467B 0.00
DocGo (DCGO) United States $0.420B 15.85
Enhabit (EHAB) United States $0.376B 32.48
COMPASS Pathways (CMPS) United Kingdom $0.304B 0.00
ModivCare (MODV) United States $0.250B 13.54
LifeMD (LFMD) United States $0.246B 0.00
Sera Prognostics (SERA) United States $0.206B 0.00
Biodesix (BDSX) United States $0.175B 0.00
Nutex Health (NUTX) United States $0.173B 0.00
Beauty Health (SKIN) United States $0.173B 0.00
MultiPlan (MPLN) United States $0.114B 0.00
Ascend Wellness Holdings (AAWH) United States $0.094B 0.00
So-Young (SY) China $0.093B 17.98
Singular Genomics Systems (OMIC) United States $0.055B 0.00
OncoCyte (OCX) United States $0.045B 0.00
NeueHealth (NEUE) United States $0.042B 1.11
Co-Diagnostics (CODX) United States $0.034B 0.00
Pheton Holdings (PTHL) China $0.031B 0.00
IceCure Medical (ICCM) Israel $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.022B 0.00
Oncology Institute (TOI) United States $0.012B 0.00
SeaStar Medical Holding (ICU) United States $0.010B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.007B 0.00
KindlyMD (KDLY) United States $0.006B 0.00
BioNexus Gene Lab (BGLC) $0.005B 0.00
ISpecimen (ISPC) United States $0.004B 0.00
NewGenIvf Group (NIVF) Thailand $0.002B 0.00
Aclarion (ACON) United States $0.002B 0.00
Cano Health (CANOQ) United States $0.001B 0.00